Analyst Ratings for Astrana Health, Inc (ASTH)
ASTH Rating Summary
ASTH Price Target Summary
- Highest: $55.00 (Truist Securities)
- Lowest: $37.00 (Jefferies)
- Average: $46.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$46.83 (+20.4%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
Avg. $ Target:
$46.83 (+20.4%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2026 | Barclays » Updated 8/7/2026 |
Andrew Mok | Upgrade | Overweight (Equalweight) |
53.00 (50.00) |
37.85 (38.91) |
2.8% | Details |
| 12/12/2025 | Needham » Updated 5/8/2026 |
Matthew Shea | New Coverage | Buy (N/A) |
41.00 (30.00) |
22.46 (38.91) |
73.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
